Lymphoma

Lymphoma
2024-11-27T03:09:35.030Z

SYMPHONY-1

SYMPHONY-1
Lymphoma

A Phase 1B/3 Double-Blind, Randomized, Active-Controlled, 3-Stage, Biomarker Adaptive Study of Tazemetostat or Placebo in Combination with Lenalidomide Plus Rituximab in Subjects with Relapsed/Refractory Follicular Lymphoma

A Phase 1B/3 Double-Blind, Randomized, Active-Controlled, 3-Stage, Biomarker Adaptive Study of Tazemetostat or Placebo in Combination with Lenalidomide Plus Rituximab in Subjects with Relapsed/Refractory Follicular Lymphoma

Trial overview

Clinical Area

Malignant Haematology

Disease / Condition

Lymphoma

Study Phase

III

Trial Identifiers
GenesisCare Location(s)
St Andrew's Precinct (Oncology)
location pin icon

Level 1, 337 South Terrace, Adelaide, SA, 5000, Australia

phone icon (08) 8228 6700 email icon infooncologysa@genesiscare.com
SA
St Andrew's Precinct (Oncology)
Principal Investigator(s)
Haematologist

Dr Anya Hotinski

BSc (Hons) BMBS PhD FRACP FRCPA

Dr Anya Hotinski
location pin icon

St Andrew's Precinct (Oncology)

View Profile
Profile Image - Dr Anya Hotinski

Thank you for submitting.

We will be in touch within 24 hours

An unexpected error has occurred.

You will need to complete the form again, sorry for the inconvenience.

How can we help?

If you have a medical emergency please call 000. If you have an urgent request and would like to speak to our staff, please contact one of our centres directly.

* Indicates a required field.